Global Bicalutamide Market Research Report 2022

Publisher Name :
Date: 03-Aug-2022
No. of pages: 93
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

- Tablets

- Capsule

Segment by Application

- Single Drug For Prostate Cancer

- Combined Chemotherapy For Prostate Cancer

- Combined Radiation Therapy Or Castration For Prostate Cancer

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- AstraZeneca

- CORDEN PHARMA GMBH

- Zeneca GmbH

- Actavis Pharma

- Sivem Pharmaceuticals

- Sorres Pharma

- Fresenius Kabi

- ANI Pharmaceuticals

- Accel Pharma

- Apotex Corporation

- Shanghai Fudan Fuhua Pharmaceutical

- Shanghai Zhaohui Pharmaceutical

- Zhejiang Haizheng Pharmaceutical

- Shanxi Zhendong Pharmaceutical

Global Bicalutamide Market Research Report 2022

Table of Contents
1 Bicalutamide Market Overview
1.1 Product Overview and Scope of Bicalutamide
1.2 Bicalutamide Segment by Type
1.2.1 Global Bicalutamide Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Tablets
1.2.3 Capsule
1.3 Bicalutamide Segment by Application
1.3.1 Global Bicalutamide Sales Comparison by Application: (2022-2028)
1.3.2 Single Drug For Prostate Cancer
1.3.3 Combined Chemotherapy For Prostate Cancer
1.3.4 Combined Radiation Therapy Or Castration For Prostate Cancer
1.4 Global Bicalutamide Market Size Estimates and Forecasts
1.4.1 Global Bicalutamide Revenue 2017-2028
1.4.2 Global Bicalutamide Sales 2017-2028
1.4.3 Bicalutamide Market Size by Region: 2017 Versus 2021 Versus 2028
2 Bicalutamide Market Competition by Manufacturers
2.1 Global Bicalutamide Sales Market Share by Manufacturers (2017-2022)
2.2 Global Bicalutamide Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Bicalutamide Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Bicalutamide Manufacturing Sites, Area Served, Product Type
2.5 Bicalutamide Market Competitive Situation and Trends
2.5.1 Bicalutamide Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Bicalutamide Players Market Share by Revenue
2.5.3 Global Bicalutamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bicalutamide Retrospective Market Scenario by Region
3.1 Global Bicalutamide Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Bicalutamide Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Bicalutamide Market Facts & Figures by Country
3.3.1 North America Bicalutamide Sales by Country
3.3.2 North America Bicalutamide Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Bicalutamide Market Facts & Figures by Country
3.4.1 Europe Bicalutamide Sales by Country
3.4.2 Europe Bicalutamide Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Bicalutamide Market Facts & Figures by Region
3.5.1 Asia Pacific Bicalutamide Sales by Region
3.5.2 Asia Pacific Bicalutamide Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Bicalutamide Market Facts & Figures by Country
3.6.1 Latin America Bicalutamide Sales by Country
3.6.2 Latin America Bicalutamide Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Bicalutamide Market Facts & Figures by Country
3.7.1 Middle East and Africa Bicalutamide Sales by Country
3.7.2 Middle East and Africa Bicalutamide Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Bicalutamide Historic Market Analysis by Type
4.1 Global Bicalutamide Sales Market Share by Type (2017-2022)
4.2 Global Bicalutamide Revenue Market Share by Type (2017-2022)
4.3 Global Bicalutamide Price by Type (2017-2022)
5 Global Bicalutamide Historic Market Analysis by Application
5.1 Global Bicalutamide Sales Market Share by Application (2017-2022)
5.2 Global Bicalutamide Revenue Market Share by Application (2017-2022)
5.3 Global Bicalutamide Price by Application (2017-2022)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Corporation Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Bicalutamide Sales, Revenue and Gross Margin (2017-2022)
6.1.4 AstraZeneca Bicalutamide Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 CORDEN PHARMA GMBH
6.2.1 CORDEN PHARMA GMBH Corporation Information
6.2.2 CORDEN PHARMA GMBH Description and Business Overview
6.2.3 CORDEN PHARMA GMBH Bicalutamide Sales, Revenue and Gross Margin (2017-2022)
6.2.4 CORDEN PHARMA GMBH Bicalutamide Product Portfolio
6.2.5 CORDEN PHARMA GMBH Recent Developments/Updates
6.3 Zeneca GmbH
6.3.1 Zeneca GmbH Corporation Information
6.3.2 Zeneca GmbH Description and Business Overview
6.3.3 Zeneca GmbH Bicalutamide Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Zeneca GmbH Bicalutamide Product Portfolio
6.3.5 Zeneca GmbH Recent Developments/Updates
6.4 Actavis Pharma
6.4.1 Actavis Pharma Corporation Information
6.4.2 Actavis Pharma Description and Business Overview
6.4.3 Actavis Pharma Bicalutamide Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Actavis Pharma Bicalutamide Product Portfolio
6.4.5 Actavis Pharma Recent Developments/Updates
6.5 Sivem Pharmaceuticals
6.5.1 Sivem Pharmaceuticals Corporation Information
6.5.2 Sivem Pharmaceuticals Description and Business Overview
6.5.3 Sivem Pharmaceuticals Bicalutamide Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Sivem Pharmaceuticals Bicalutamide Product Portfolio
6.5.5 Sivem Pharmaceuticals Recent Developments/Updates
6.6 Sorres Pharma
6.6.1 Sorres Pharma Corporation Information
6.6.2 Sorres Pharma Description and Business Overview
6.6.3 Sorres Pharma Bicalutamide Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Sorres Pharma Bicalutamide Product Portfolio
6.6.5 Sorres Pharma Recent Developments/Updates
6.7 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Bicalutamide Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Fresenius Kabi Bicalutamide Product Portfolio
6.7.5 Fresenius Kabi Recent Developments/Updates
6.8 ANI Pharmaceuticals
6.8.1 ANI Pharmaceuticals Corporation Information
6.8.2 ANI Pharmaceuticals Description and Business Overview
6.8.3 ANI Pharmaceuticals Bicalutamide Sales, Revenue and Gross Margin (2017-2022)
6.8.4 ANI Pharmaceuticals Bicalutamide Product Portfolio
6.8.5 ANI Pharmaceuticals Recent Developments/Updates
6.9 Accel Pharma
6.9.1 Accel Pharma Corporation Information
6.9.2 Accel Pharma Description and Business Overview
6.9.3 Accel Pharma Bicalutamide Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Accel Pharma Bicalutamide Product Portfolio
6.9.5 Accel Pharma Recent Developments/Updates
6.10 Apotex Corporation
6.10.1 Apotex Corporation Corporation Information
6.10.2 Apotex Corporation Description and Business Overview
6.10.3 Apotex Corporation Bicalutamide Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Apotex Corporation Bicalutamide Product Portfolio
6.10.5 Apotex Corporation Recent Developments/Updates
6.11 Shanghai Fudan Fuhua Pharmaceutical
6.11.1 Shanghai Fudan Fuhua Pharmaceutical Corporation Information
6.11.2 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Description and Business Overview
6.11.3 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product Portfolio
6.11.5 Shanghai Fudan Fuhua Pharmaceutical Recent Developments/Updates
6.12 Shanghai Zhaohui Pharmaceutical
6.12.1 Shanghai Zhaohui Pharmaceutical Corporation Information
6.12.2 Shanghai Zhaohui Pharmaceutical Bicalutamide Description and Business Overview
6.12.3 Shanghai Zhaohui Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Shanghai Zhaohui Pharmaceutical Bicalutamide Product Portfolio
6.12.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
6.13 Zhejiang Haizheng Pharmaceutical
6.13.1 Zhejiang Haizheng Pharmaceutical Corporation Information
6.13.2 Zhejiang Haizheng Pharmaceutical Bicalutamide Description and Business Overview
6.13.3 Zhejiang Haizheng Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Zhejiang Haizheng Pharmaceutical Bicalutamide Product Portfolio
6.13.5 Zhejiang Haizheng Pharmaceutical Recent Developments/Updates
6.14 Shanxi Zhendong Pharmaceutical
6.14.1 Shanxi Zhendong Pharmaceutical Corporation Information
6.14.2 Shanxi Zhendong Pharmaceutical Bicalutamide Description and Business Overview
6.14.3 Shanxi Zhendong Pharmaceutical Bicalutamide Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Shanxi Zhendong Pharmaceutical Bicalutamide Product Portfolio
6.14.5 Shanxi Zhendong Pharmaceutical Recent Developments/Updates
7 Bicalutamide Manufacturing Cost Analysis
7.1 Bicalutamide Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Bicalutamide
7.4 Bicalutamide Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Bicalutamide Distributors List
8.3 Bicalutamide Customers
9 Bicalutamide Market Dynamics
9.1 Bicalutamide Industry Trends
9.2 Bicalutamide Market Drivers
9.3 Bicalutamide Market Challenges
9.4 Bicalutamide Market Restraints
10 Global Market Forecast
10.1 Bicalutamide Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Bicalutamide by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Bicalutamide by Type (2023-2028)
10.2 Bicalutamide Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Bicalutamide by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Bicalutamide by Application (2023-2028)
10.3 Bicalutamide Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Bicalutamide by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Bicalutamide by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Bicalutamide Sales Growth Rate Comparison by Type (2022-2028) & (M Pcs) & (US$ Million)
Table 2. Global Bicalutamide Sales Growth Rate Comparison by Application (2022-2028) & (M Pcs) & (US$ Million)
Table 3. Global Bicalutamide Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Bicalutamide Market Competitive Situation by Manufacturers in 2021
Table 5. Global Bicalutamide Sales (M Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Bicalutamide Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Bicalutamide Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Bicalutamide Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Bicalutamide Average Price (US$/Pcs) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Bicalutamide Manufacturing Sites and Area Served
Table 11. Manufacturers Bicalutamide Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Bicalutamide by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bicalutamide as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Bicalutamide Sales by Region (2017-2022) & (M Pcs)
Table 16. Global Bicalutamide Sales Market Share by Region (2017-2022)
Table 17. Global Bicalutamide Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Bicalutamide Revenue Market Share by Region (2017-2022)
Table 19. North America Bicalutamide Sales by Country (2017-2022) & (M Pcs)
Table 20. North America Bicalutamide Sales Market Share by Country (2017-2022)
Table 21. North America Bicalutamide Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Bicalutamide Revenue Market Share by Country (2017-2022)
Table 23. Europe Bicalutamide Sales by Country (2017-2022) & (M Pcs)
Table 24. Europe Bicalutamide Sales Market Share by Country (2017-2022)
Table 25. Europe Bicalutamide Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Bicalutamide Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Bicalutamide Sales by Region (2017-2022) & (M Pcs)
Table 28. Asia Pacific Bicalutamide Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Bicalutamide Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Bicalutamide Revenue Market Share by Region (2017-2022)
Table 31. Latin America Bicalutamide Sales by Country (2017-2022) & (M Pcs)
Table 32. Latin America Bicalutamide Sales Market Share by Country (2017-2022)
Table 33. Latin America Bicalutamide Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Bicalutamide Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Bicalutamide Sales by Country (2017-2022) & (M Pcs)
Table 36. Middle East and Africa Bicalutamide Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Bicalutamide Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Bicalutamide Revenue Market Share by Country (2017-2022)
Table 39. Global Bicalutamide Sales by Type (2017-2022) & (M Pcs)
Table 40. Global Bicalutamide Sales Market Share by Type (2017-2022)
Table 41. Global Bicalutamide Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Bicalutamide Revenue Share by Type (2017-2022)
Table 43. Global Bicalutamide Price by Type (2017-2022) & (US$/Pcs)
Table 44. Global Bicalutamide Sales (M Pcs) by Application (2017-2022)
Table 45. Global Bicalutamide Sales Market Share by Application (2017-2022)
Table 46. Global Bicalutamide Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Bicalutamide Revenue Share by Application (2017-2022)
Table 48. Global Bicalutamide Price by Application (2017-2022) & (US$/Pcs)
Table 49. AstraZeneca Corporation Information
Table 50. AstraZeneca Description and Business Overview
Table 51. AstraZeneca Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 52. AstraZeneca Bicalutamide Product
Table 53. AstraZeneca Recent Developments/Updates
Table 54. CORDEN PHARMA GMBH Corporation Information
Table 55. CORDEN PHARMA GMBH Description and Business Overview
Table 56. CORDEN PHARMA GMBH Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 57. CORDEN PHARMA GMBH Bicalutamide Product
Table 58. CORDEN PHARMA GMBH Recent Developments/Updates
Table 59. Zeneca GmbH Corporation Information
Table 60. Zeneca GmbH Description and Business Overview
Table 61. Zeneca GmbH Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 62. Zeneca GmbH Bicalutamide Product
Table 63. Zeneca GmbH Recent Developments/Updates
Table 64. Actavis Pharma Corporation Information
Table 65. Actavis Pharma Description and Business Overview
Table 66. Actavis Pharma Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 67. Actavis Pharma Bicalutamide Product
Table 68. Actavis Pharma Recent Developments/Updates
Table 69. Sivem Pharmaceuticals Corporation Information
Table 70. Sivem Pharmaceuticals Description and Business Overview
Table 71. Sivem Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 72. Sivem Pharmaceuticals Bicalutamide Product
Table 73. Sivem Pharmaceuticals Recent Developments/Updates
Table 74. Sorres Pharma Corporation Information
Table 75. Sorres Pharma Description and Business Overview
Table 76. Sorres Pharma Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 77. Sorres Pharma Bicalutamide Product
Table 78. Sorres Pharma Recent Developments/Updates
Table 79. Fresenius Kabi Corporation Information
Table 80. Fresenius Kabi Description and Business Overview
Table 81. Fresenius Kabi Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 82. Fresenius Kabi Bicalutamide Product
Table 83. Fresenius Kabi Recent Developments/Updates
Table 84. ANI Pharmaceuticals Corporation Information
Table 85. ANI Pharmaceuticals Description and Business Overview
Table 86. ANI Pharmaceuticals Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 87. ANI Pharmaceuticals Bicalutamide Product
Table 88. ANI Pharmaceuticals Recent Developments/Updates
Table 89. Accel Pharma Corporation Information
Table 90. Accel Pharma Description and Business Overview
Table 91. Accel Pharma Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 92. Accel Pharma Bicalutamide Product
Table 93. Accel Pharma Recent Developments/Updates
Table 94. Apotex Corporation Corporation Information
Table 95. Apotex Corporation Description and Business Overview
Table 96. Apotex Corporation Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 97. Apotex Corporation Bicalutamide Product
Table 98. Apotex Corporation Recent Developments/Updates
Table 99. Shanghai Fudan Fuhua Pharmaceutical Corporation Information
Table 100. Shanghai Fudan Fuhua Pharmaceutical Description and Business Overview
Table 101. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 102. Shanghai Fudan Fuhua Pharmaceutical Bicalutamide Product
Table 103. Shanghai Fudan Fuhua Pharmaceutical Recent Developments/Updates
Table 104. Shanghai Zhaohui Pharmaceutical Corporation Information
Table 105. Shanghai Zhaohui Pharmaceutical Description and Business Overview
Table 106. Shanghai Zhaohui Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 107. Shanghai Zhaohui Pharmaceutical Bicalutamide Product
Table 108. Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
Table 109. Zhejiang Haizheng Pharmaceutical Corporation Information
Table 110. Zhejiang Haizheng Pharmaceutical Description and Business Overview
Table 111. Zhejiang Haizheng Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 112. Zhejiang Haizheng Pharmaceutical Bicalutamide Product
Table 113. Zhejiang Haizheng Pharmaceutical Recent Developments/Updates
Table 114. Shanxi Zhendong Pharmaceutical Corporation Information
Table 115. Shanxi Zhendong Pharmaceutical Description and Business Overview
Table 116. Shanxi Zhendong Pharmaceutical Bicalutamide Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 117. Shanxi Zhendong Pharmaceutical Bicalutamide Product
Table 118. Shanxi Zhendong Pharmaceutical Recent Developments/Updates
Table 119. Production Base and Market Concentration Rate of Raw Material
Table 120. Key Suppliers of Raw Materials
Table 121. Bicalutamide Distributors List
Table 122. Bicalutamide Customers List
Table 123. Bicalutamide Market Trends
Table 124. Bicalutamide Market Drivers
Table 125. Bicalutamide Market Challenges
Table 126. Bicalutamide Market Restraints
Table 127. Global Bicalutamide Sales Forecast by Type (2023-2028) & (M Pcs)
Table 128. Global Bicalutamide Sales Market Share Forecast by Type (2023-2028)
Table 129. Global Bicalutamide Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 130. Global Bicalutamide Revenue Market Share Forecast by Type (2023-2028)
Table 131. Global Bicalutamide Sales Forecast by Application (2023-2028) & (M Pcs)
Table 132. Global Bicalutamide Sales Market Share Forecast by Application (2023-2028)
Table 133. Global Bicalutamide Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 134. Global Bicalutamide Revenue Market Share Forecast by Application (2023-2028)
Table 135. Global Bicalutamide Sales Forecast by Region (2023-2028) & (M Pcs)
Table 136. Global Bicalutamide Sales Market Share Forecast by Region (2023-2028)
Table 137. Global Bicalutamide Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 138. Global Bicalutamide Revenue Market Share Forecast by Region (2023-2028)
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bicalutamide
Figure 2. Global Bicalutamide Market Share by Type in 2021 & 2028
Figure 3. Tablets Product Picture
Figure 4. Capsule Product Picture
Figure 5. Global Bicalutamide Market Share by Application in 2021 & 2028
Figure 6. Single Drug For Prostate Cancer
Figure 7. Combined Chemotherapy For Prostate Cancer
Figure 8. Combined Radiation Therapy Or Castration For Prostate Cancer
Figure 9. Global Bicalutamide Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Bicalutamide Market Size (2017-2028) & (US$ Million)
Figure 11. Global Bicalutamide Sales (2017-2028) & (M Pcs)
Figure 12. Bicalutamide Sales Share by Manufacturers in 2021
Figure 13. Global Bicalutamide Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Bicalutamide Players: Market Share by Revenue in 2021
Figure 15. Bicalutamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Bicalutamide Sales Market Share by Region (2017-2022)
Figure 17. Global Bicalutamide Sales Market Share by Region in 2021
Figure 18. Global Bicalutamide Revenue Market Share by Region (2017-2022)
Figure 19. Global Bicalutamide Revenue Market Share by Region in 2021
Figure 20. U.S. Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Taiwan Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Philippines Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Vietnam Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Mexico Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Brazil Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Argentina Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Bicalutamide Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Bicalutamide by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Bicalutamide
Figure 46. Manufacturing Process Analysis of Bicalutamide
Figure 47. Bicalutamide Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
  • Rhabdomyosarcoma Drug Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application
    Published: 14-Aug-2022        Price: US 3500 Onwards        Pages: 94
    This report describes the global market size of Rhabdomyosarcoma Drug from 2017 to 2021 and its CAGR from 2017 to 2021, and also forecasts its market size to the end of 2027 and its CAGR from 2022 to 2027. For geography segment, regional supply, demand, major players, price is presented from 2017 to 2027. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also in......
  • Global Bicalutamide Market Research Report 2022
    Published: 03-Aug-2022        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Tablets - Capsule Segment by Application - Single Drug For Prostate Cancer - Combined......
  • (Post-pandemic Era) - Global Immunotherapy Drugs Market Segment Research Report 2022
    Published: 02-Aug-2022        Price: US 3350 Onwards        Pages: 85
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • Post-pandemic Era - Global Immunotherapy Drugs Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
    Published: 02-Aug-2022        Price: US 4860 Onwards        Pages: 87
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • (Post-pandemic Era) - Global Hematological Malignancies Disease Market Segment Research Report 2022
    Published: 02-Aug-2022        Price: US 3350 Onwards        Pages: 116
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • Post-pandemic Era - Global Hematological Malignancies Disease Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
    Published: 02-Aug-2022        Price: US 4860 Onwards        Pages: 114
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • (Post-pandemic Era) - Global Hepatocellular Carcinoma Drugs Market Segment Research Report 2022
    Published: 02-Aug-2022        Price: US 3350 Onwards        Pages: 98
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • Post-pandemic Era - Global Hepatocellular Carcinoma Drugs Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
    Published: 02-Aug-2022        Price: US 4860 Onwards        Pages: 94
    Summary The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery. 2022 is a year of continuous recovery. Global supply chain disturba......
  • Sickle Cell Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
    Published: 29-Jul-2022        Price: US 2500 Onwards        Pages: 277
    Sickle Cell Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Sickle Cell Disease - Drugs In Development, 2022, provides an overview of the Sickle Cell Disease (Hematological Disorders) pipeline landscape. Sickle cell anemia is a genetic (inherited) blood disorder in which red blood cells, which carry oxygen around t......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs